Trademark: 79169811
Word
NUPREVIQ
Status Date
Monday, July 11, 2022
Registration Number
4872533
Registration Date
Tuesday, December 22, 2015
Filing Date
Friday, May 15, 2015
Published for Opposition
Tuesday, October 6, 2015
44 Medical testing of patients for determining individual risk of forming inhibitors during a hemophilia treatment with factor VIII
Sep 16, 2015
Notification Of Possible Opposition Sent To Ib
Jul 30, 2015
Sn Assigned For Sect 66a Appl From Ib
Aug 6, 2015
New Application Office Supplied Data Entered
Aug 11, 2015
Application Filing Receipt Mailed
Aug 27, 2015
Assigned To Examiner
Aug 31, 2015
Approved For Pub - Principal Register
Sep 16, 2015
Notice Of Publication
Sep 16, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 18, 2016
New Representative At Ib Received
Sep 24, 2015
New Representative At Ib Received
Oct 2, 2015
Notification Processed By Ib
Oct 6, 2015
Published For Opposition
Dec 22, 2015
Registered-Principal Register
Jan 21, 2016
Grant Of Protection Created, To Be Sent To Ib
Mar 24, 2016
Final Disposition Processed
Mar 24, 2016
Final Disposition Notice Sent To Ib
Aug 11, 2016
New Representative At Ib Received
Aug 11, 2016
New Representative At Ib Received
Jul 11, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Aug 19, 2016
Notification Processed By Ib
Dec 21, 2021
Teas Section 71 Received
Jun 6, 2022
Case Assigned To Post Registration Paralegal
Jul 11, 2022
Registered-Sec.71 Accepted
Jun 5, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 5, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 5, 2024
Teas Change Of Correspondence Received
Trademark Alertz updated from USPTO on 2030-01-24
